drugset / Trial / NCT00271505
Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to evaluate the effectiveness of Avastin® in combination with docetaxel and carboplatin in the treatment of lung cancer. The safety of this combination will also be studied.
Timeline
- Start
- 2005-12-05
- Primary completion
- 2017-07-27
- Completion
- 2017-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 15 mg/kg | Intravenous |
| Subject | Carboplatin | Small molecule | — | Intravenous |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |